Physician profile
Vikram Rajan
NPI 1619186194
$23,419.65
in general payments reported to CMS, 2019-2025
50 companies · $3,007 in 2025
The $3,007 reported for 2025 was more than what 88% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,258 · 2020: $1,652 · 2021: $2,989 · 2022: $2,818 · 2023: $3,436 · 2024: $7,261 · 2025: $3,007.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,507 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $3,944 · Travel and Lodging: $251.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,507.18 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $3,944.15 |
| Travel and Lodging | $251.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $5,375.09 | 2019-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $1,909.35 | 2019-2025 | Eliquis, Camzyos |
| Novartis Pharmaceuticals Corporation | $1,722.39 | 2019-2025 | |
| Janssen Pharmaceuticals, INC | $1,704.63 | 2019-2024 | Xarelto |
| Abbott Laboratories | $1,574.58 | 2019-2025 | Jot Dx, Aveir, Mitraclip |
| Medtronic, INC. | $1,374.78 | 2021-2025 | Micra, Affera Mapping System, Linq II |
| Pfizer INC. | $841.44 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $824.80 | 2019-2024 | |
| Boston Scientific Corporation | $745.75 | 2021-2025 | Lux-Dx Insertable Cardiac Monitor, Accolade Sr, Watchman |
| Alnylam Pharmaceuticals INC. | $556.98 | 2019-2025 | Amvuttra, Onpattro |
| Merck Sharp & Dohme LLC | $514.60 | 2021-2025 | Verquvo |
| Philips North America LLC | $487.04 | 2023-2025 | Igt Devices Undivided, (Cm9) Amb Mon & Diag Und |
| Cardiva Medical, INC. | $484.42 | 2023-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $383.14 | 2019-2025 | Lifevest |
| Biotronik INC. | $349.73 | 2019-2021 |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $338.28 | 2019-2025 | Wainua, Farxiga |
| Esperion Therapeutics, INC. | $325.03 | 2020-2025 | Nexletol |
| Medtronic Vascular, INC. | $309.93 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $273.44 | 2023-2025 | Jardiance |
| Biosense Webster, INC. | $258.02 | 2019-2024 | Carto 3 |
| Regeneron Healthcare Solutions, INC. | $222.70 | 2019-2025 | Evkeeza |
| Cvrx, INC. | $217.86 | 2023-2025 | Barostim Neo System |
| Heartflow, INC. | $210.32 | 2023-2025 | Ffrct |
| Bayer Healthcare Pharmaceuticals INC. | $205.26 | 2023-2025 | |
| Edwards Lifesciences Corporation | $192.41 | 2019-2024 | Sapien 3 Ultra Resilia |
| Irhythm Technologies, INC. | $179.33 | 2022-2024 | Zio Xt Patch, Zio Monitor |
| Kiniksa Pharmaceuticals International, Plc | $175.02 | 2024 | Arcalyst |
| Kiniksa Pharmaceuticals, Ltd. | $174.24 | 2021-2023 | Arcalyst |
| Lexicon Pharmaceuticals, INC. | $157.19 | 2023-2024 | Inpefa |
| Bridgebio Pharma, INC. | $147.46 | 2025 | Attruby |
| Bardy Diagnostics, INC. | $140.48 | 2019-2022 | |
| Actelion Pharmaceuticals US, INC. | $137.67 | 2021-2023 | Opsumit, Uptravi |
| Chiesi USA, INC. | $123.68 | 2020-2022 | |
| Itamar Medical INC | $86.32 | 2022-2023 | Watchpatone |
| Impulse Dynamics (USA) INC. | $83.52 | 2023-2024 | Optimizer, Optimizer |
| Bard Peripheral Vascular, INC. | $72.50 | 2022-2023 | Venclose Maven Catheter |
| Gilead Sciences, INC. | $71.02 | 2019 | |
| Amarin Pharma, INC. | $69.45 | 2019-2021 | |
| Arbor Pharmaceuticals, INC. | $65.39 | 2020-2021 | |
| Kowa Pharmaceuticals America, INC. | $55.87 | 2019-2021 | |
| Acist Medical Systems, INC. | $47.55 | 2019 | |
| Lilly USA, LLC | $45.67 | 2025 | Zepbound |
| Bsn Medical INC | $27.29 | 2022 | |
| Kestra Medical Technology Services, INC. | $26.30 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $24.90 | 2019 | |
| Novo Nordisk INC | $23.23 | 2022 | |
| Baxter Healthcare | $22.70 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
| Tactile Systems Technology INC | $22.38 | 2022 | |
| Altathera Pharmaceuticals LLC | $21.78 | 2024 | Sotalol Hydrochloride |
| Cardiovascular Systems INC. | $16.74 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Vikram Rajan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.